Evidence map›Paper›PMID 34722313›Full record

ArticleFrontiers in oncology2021

Predicting Axillary Lymph Node Metastasis in Early Breast Cancer Using Deep Learning on Primary Tumor Biopsy Slides.

Feng Xu, Chuang Zhu, Wenqi Tang, Ying Wang, Yu Zhang, Jie Li, Hongchuan Jiang, Zhongyue Shi, Jun Liu, Mulan Jin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Feng XuDepartment of Breast Surgery, Beijing Chao-Yang Hospital, Beijing, China.
Chuang ZhuSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Wenqi TangSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Ying WangDepartment of Pathology, Beijing Chao-Yang Hospital, Beijing, China.
Yu ZhangSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Jie LiDepartment of Breast Surgery, Beijing Chao-Yang Hospital, Beijing, China.
Hongchuan JiangDepartment of Breast Surgery, Beijing Chao-Yang Hospital, Beijing, China.
Zhongyue ShiDepartment of Pathology, Beijing Chao-Yang Hospital, Beijing, China.
Jun LiuSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Mulan JinDepartment of Pathology, Beijing Chao-Yang Hospital, Beijing, China.
Beijing Chao-Yang Hospital · CNBeijing University of Posts and Telecommunications · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop and validate a deep learning (DL)-based primary tumor biopsy signature for predicting axillary lymph node (ALN) metastasis preoperatively in early breast cancer (EBC) patients with clinically negative ALN.

methodsA total of 1,058 EBC patients with pathologically confirmed ALN status were enrolled from May 2010 to August 2020. A DL core-needle biopsy (DL-CNB) model was built on the attention-based multiple instance-learning (AMIL) framework to predict ALN status utilizing the DL features, which were extracted from the cancer areas of digitized whole-slide images (WSIs) of breast CNB specimens annotated by two pathologists. Accuracy, sensitivity, specificity, receiver operating characteristic (ROC) curves, and areas under the ROC curve (AUCs) were analyzed to evaluate our model.

resultsThe best-performing DL-CNB model with VGG16_BN as the feature extractor achieved an AUC of 0.816 (95% confidence interval (CI): 0.758, 0.865) in predicting positive ALN metastasis in the independent test cohort. Furthermore, our model incorporating the clinical data, which was called DL-CNB+C, yielded the best accuracy of 0.831 (95%CI: 0.775, 0.878), especially for patients younger than 50 years (AUC: 0.918, 95%CI: 0.825, 0.971). The interpretation of DL-CNB model showed that the top signatures most predictive of ALN metastasis were characterized by the nucleus features including density (

conclusionOur study provides a novel DL-based biomarker on primary tumor CNB slides to predict the metastatic status of ALN preoperatively for patients with EBC.

Indexed as

axillary lymph node metastasisbreast cancercore-needle biopsydeep learningwhole-slide images

Identifiers

PMID34722313
PMCPMC8551965
OpenAlexW3207232829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.